Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2012		Sep. 30, 2011		Sep. 30, 2012		Sep. 30, 2011
Revenues:
Product sales	$ 1,054.5		$ 1,018.4		$ 3,309.1		$ 2,901.0
Royalties	41.8		62.8		154.4		199.8
Other revenues	4.1		4.9		16.5		20.4
Total revenues	1,100.4		1,086.1		3,480.0		3,121.2
Costs and expenses:
Cost of product sales	167.9	[1]	166.5	[1]	478.8	[1]	434.7	[1]
Research and development	224.7	[1]	201.5	[1]	683.6	[1]	556.3	[1]
Selling, general and administrative ("SG&A")	437.4	[1]	452.1	[1]	1,448.4	[1]	1,295.3	[1]
(Gain)/loss on sale of product rights	(5.7)		0.3		(16.5)		3.8
Reorganization costs	0		5.0		0		18.0
Integration and acquisition costs	2.7		5.3		15.1		7.9
Total operating expenses	827.0		830.7		2,609.4		2,316.0
Operating income	273.4		255.4		870.6		805.2
Interest income	0.9		0.3		2.3		1.5
Interest expense	(9.2)		(9.7)		(29.0)		(28.8)
Other income, net	3.5		15.6		3.6		15.9
Total other (expense)/income, net	(4.8)		6.2		(23.1)		(11.4)
Income before income taxes and equity in earnings of equity method investees	268.6		261.6		847.5		793.8
Income taxes	(41.6)		(69.5)		(144.6)		(187.3)
Equity in earnings of equity method investees, net of taxes	0.2		0.8		0.5		3.2
Net income	227.2		192.9		703.4		609.7
Numerator for basic earnings per share	227.2		192.9		703.4		609.7
Earning per ordinary share - basic
Earnings per ordinary share - basic	$ 0.409		$ 0.350		$ 1.266		$ 1.106
Earnings per ordinary share - diluted
Earnings per ordinary share - diluted	$ 0.396		$ 0.339		$ 1.224		$ 1.067
Weighted average number of shares:
Basic	555.9		551.3		555.5		551.2
Diluted	593.1		593.8		594.0		595.0
Amounts attributable to Shire plc
Numerator for basic earnings per share	$ 227.2		$ 192.9		$ 703.4		$ 609.7

[1] Cost of product sales includes amortization of intangible assets relating to favorable manufacturing contracts of $nil for the three months to September 30, 2012 (2011: $0.5 million) and $0.7 million for the nine months to September 30, 2012 (2011: $1.4 million). Research and development costs include intangible asset impairment charges of $nil (2011: $16.0 million) for the three months to September 30, 2012 and $27.0 million for the nine months to September 30, 2012 (2011: $16.0 million). SG&A costs includes amortization of intangible assets relating to intellectual property rights acquired of $50.0 million for the three months to September 30, 2012 (2011: $46.4 million) and $146.6 million for the nine months to September 30, 2012 (2011: $119.1 million.)